Anika Therapeutics, Inc. Costs and Expenses
Anika Therapeutics, Inc. (ANIK) reported Costs and Expenses of $18.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-07-29
- Anika Therapeutics, Inc. costs and expenses for the quarter ending 2026-06-30 was $18.29M, a 1.36% decline year-over-year.
- Anika Therapeutics, Inc. costs and expenses for the quarter ending 2026-03-31 was $24.48M, a 29.11% increase year-over-year.
- Anika Therapeutics, Inc. costs and expenses for the quarter ending 2025-12-31 was $18.53M, a 3.94% increase year-over-year.
- Anika Therapeutics, Inc. costs and expenses for the quarter ending 2025-09-30 was $18.82M, a 3.45% decline year-over-year.
- Anika Therapeutics, Inc. costs and expenses for fiscal 2025 was $74.86M, a 7.70% decline from fiscal 2024.
- Anika Therapeutics, Inc. costs and expenses for fiscal 2024 was $81.10M, a 0.72% decline from fiscal 2023.
- Anika Therapeutics, Inc. costs and expenses for fiscal 2023 was $81.69M, a 17.45% increase from fiscal 2022.
- Anika Therapeutics, Inc. costs and expenses for fiscal 2022 was $69.55M, a 13.42% decline from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.29M 10-Q · filed 2026-07-29 | $42.77M 10-Q · filed 2026-07-29 | $61.31M derived: sum of 3 quarters · filed 2026-07-29 | $80.13M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $24.48M 10-Q · filed 2026-04-30 | $43.02M derived: sum of 2 quarters · filed 2026-04-30 | $61.84M derived: sum of 3 quarters · filed 2026-04-30 | $80.38M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $18.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $37.35M derived: sum of 2 quarters · filed 2026-03-03 | $55.89M derived: sum of 3 quarters · filed 2026-07-29 | $74.86M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $18.82M 10-Q · filed 2025-11-05 | $37.36M derived: sum of 2 quarters · filed 2026-07-29 | $56.33M 10-Q · filed 2025-11-05 | $74.16M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $18.54M 10-Q · filed 2026-07-29 | $37.51M 10-Q · filed 2026-07-29 | $55.34M derived: sum of 3 quarters · filed 2026-07-29 | $74.83M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $18.96M 10-Q · filed 2026-04-30 | $36.80M derived: sum of 2 quarters · filed 2026-04-30 | $56.28M derived: sum of 3 quarters · filed 2026-04-30 | $78.58M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $17.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $37.32M derived: sum of 2 quarters · filed 2026-03-03 | $59.62M derived: sum of 3 quarters · filed 2026-03-03 | $81.10M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $19.49M 10-Q · filed 2025-11-05 | $29.46M 10-Q · filed 2024-11-04 | $41.79M derived: sum of 2 quarters · filed 2025-11-05 | $63.27M 10-Q · filed 2025-11-05 | $86.35M 10-Q · filed 2024-11-04 | $44.34M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-06-30 | $22.30M 10-Q · filed 2025-07-30 | $27.20M 10-Q · filed 2024-08-08 | $43.78M 10-Q · filed 2025-07-30 | $56.90M 10-Q · filed 2024-08-08 | $24.85M derived: sum of 3 quarters · filed 2026-03-03 | $57.47M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-03-31 | $21.48M 10-Q · filed 2025-05-09 | $29.69M 10-Q · filed 2024-05-08 | $2.55M derived: sum of 2 quarters · filed 2026-03-03 | $35.17M derived: sum of 3 quarters · filed 2026-03-03 | $67.77M derived: sum of 4 quarters · filed 2026-03-03 | |||
| 2023-12-31 | -$18.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $13.69M derived: sum of 2 quarters · filed 2026-03-03 | $46.29M derived: sum of 3 quarters · filed 2026-03-03 | $81.69M 10-K · filed 2026-03-03 | $190.73M 10-K · filed 2024-03-15 | |||
| 2023-09-30 | $32.62M 10-Q · filed 2024-11-04 | $65.22M derived: sum of 2 quarters · filed 2024-11-04 | $100.62M 10-Q · filed 2024-11-04 | $87.99M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | $32.60M 10-Q · filed 2024-08-08 | $68.00M 10-Q · filed 2024-08-08 | $55.37M derived: sum of 3 quarters · filed 2025-03-17 | $83.95M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | $35.40M 10-Q · filed 2024-05-08 | $22.77M derived: sum of 2 quarters · filed 2025-03-17 | $51.34M derived: sum of 3 quarters · filed 2025-03-17 | $79.59M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $15.95M derived: sum of 2 quarters · filed 2025-03-17 | $44.19M derived: sum of 3 quarters · filed 2025-03-17 | $69.55M 10-K · filed 2025-03-17 | $112.98M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $28.58M 10-Q · filed 2023-11-03 | $56.82M derived: sum of 2 quarters · filed 2023-11-03 | $82.18M 10-Q · filed 2023-11-03 | $109.44M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | $28.24M 10-Q · filed 2023-08-08 | $53.60M 10-Q · filed 2023-08-08 | $80.86M derived: sum of 3 quarters · filed 2024-03-15 | $102.58M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | $25.36M 10-Q · filed 2023-05-09 | $52.62M derived: sum of 2 quarters · filed 2024-03-15 | $74.34M derived: sum of 3 quarters · filed 2024-03-15 | $85.97M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | $27.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $48.98M derived: sum of 2 quarters · filed 2024-03-15 | $60.61M derived: sum of 3 quarters · filed 2024-03-15 | $80.33M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | $21.72M 10-Q · filed 2022-11-09 | $33.35M derived: sum of 2 quarters · filed 2022-11-09 | $53.07M 10-Q · filed 2022-11-09 | $87.77M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $11.63M 10-Q · filed 2022-08-04 | $31.35M 10-Q · filed 2022-08-04 | $66.05M derived: sum of 3 quarters · filed 2023-03-16 | $91.31M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $19.72M 10-Q · filed 2022-05-06 | $54.41M derived: sum of 2 quarters · filed 2023-03-16 | $79.68M derived: sum of 3 quarters · filed 2023-03-16 | $102.96M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $34.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $59.97M derived: sum of 2 quarters · filed 2023-03-16 | $83.25M derived: sum of 3 quarters · filed 2023-03-16 | $97.35M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $25.27M 10-Q · filed 2021-11-05 | $39.62M 10-Q · filed 2020-11-05 | $48.55M derived: sum of 2 quarters · filed 2021-11-05 | $62.65M 10-Q · filed 2021-11-05 | $108.14M 10-Q · filed 2020-11-05 | $58.87M derived: sum of 4 quarters · filed 2022-03-11 | ||
| 2020-06-30 | $23.28M 10-Q · filed 2021-08-06 | $40.21M 10-Q · filed 2020-08-07 | $37.38M 10-Q · filed 2021-08-06 | $68.52M 10-Q · filed 2020-08-07 | $33.60M derived: sum of 3 quarters · filed 2022-03-11 | $51.25M derived: sum of 4 quarters · filed 2022-03-11 | ||
| 2020-03-31 | $14.10M 10-Q · filed 2021-05-07 | $28.30M 10-Q · filed 2020-05-22 | $10.33M derived: sum of 2 quarters · filed 2022-03-11 | $27.97M derived: sum of 3 quarters · filed 2022-03-11 | $46.48M derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2019-12-31 | -$3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $13.87M derived: sum of 2 quarters · filed 2022-03-11 | $32.37M derived: sum of 3 quarters · filed 2022-03-11 | $51.62M 10-K · filed 2022-03-11 | $80.36M 10-K · filed 2020-03-06 | |||
| 2019-09-30 | $17.65M 10-Q · filed 2020-11-05 | $36.15M derived: sum of 2 quarters · filed 2020-11-05 | $55.39M 10-Q · filed 2020-11-05 | $41.31M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-06-30 | $18.50M 10-Q · filed 2020-08-07 | $37.74M 10-Q · filed 2020-08-07 | $23.66M derived: sum of 3 quarters · filed 2021-04-26 | $41.87M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-03-31 | $19.24M 10-Q · filed 2020-05-22 | $5.16M derived: sum of 2 quarters · filed 2021-04-26 | $23.37M derived: sum of 3 quarters · filed 2021-04-26 | $42.67M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2018-12-31 | -$14.09M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | $4.13M derived: sum of 2 quarters · filed 2021-04-26 | $23.43M derived: sum of 3 quarters · filed 2021-04-26 | $52.53M 10-K/A · filed 2021-04-26 | $83.81M 10-K · filed 2019-02-27 | |||
| 2018-09-30 | $18.21M 10-Q · filed 2019-10-28 | $37.52M derived: sum of 2 quarters · filed 2019-10-28 | $66.61M 10-Q · filed 2019-10-28 | $86.27M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-06-30 | $19.30M 10-Q · filed 2019-07-26 | $48.40M 10-Q · filed 2019-07-26 | $68.06M derived: sum of 3 quarters · filed 2020-03-06 | $84.97M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-03-31 | $29.10M 10-Q · filed 2019-05-06 | $48.76M derived: sum of 2 quarters · filed 2020-03-06 | $65.67M derived: sum of 3 quarters · filed 2020-03-06 | $81.41M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2017-12-31 | $19.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $36.58M derived: sum of 2 quarters · filed 2020-03-06 | $52.31M derived: sum of 3 quarters · filed 2020-03-06 | $67.69M 10-K · filed 2020-03-06 | ||||
| 2017-09-30 | $16.91M 10-Q · filed 2018-10-26 | $32.65M derived: sum of 2 quarters · filed 2018-10-26 | $48.03M 10-Q · filed 2018-10-26 | $64.02M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $15.74M 10-Q · filed 2018-07-31 | $31.12M 10-Q · filed 2018-07-31 | $47.10M derived: sum of 3 quarters · filed 2019-02-27 | $59.20M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $15.38M 10-Q · filed 2018-05-10 | $31.37M derived: sum of 2 quarters · filed 2019-02-27 | $43.47M derived: sum of 3 quarters · filed 2019-02-27 | $56.58M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $15.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $28.09M derived: sum of 2 quarters · filed 2019-02-27 | $41.20M derived: sum of 3 quarters · filed 2019-02-27 | $52.77M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $12.10M 10-Q · filed 2017-10-27 | $25.21M derived: sum of 2 quarters · filed 2017-10-27 | $36.79M 10-Q · filed 2017-10-27 | $50.61M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $13.11M 10-Q · filed 2017-07-28 | $24.69M 10-Q · filed 2017-07-28 | $38.51M derived: sum of 3 quarters · filed 2018-02-27 | $49.06M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $11.57M 10-Q · filed 2017-05-04 | $25.40M derived: sum of 2 quarters · filed 2018-02-27 | $35.95M derived: sum of 3 quarters · filed 2018-02-27 | $46.42M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $13.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $24.37M derived: sum of 2 quarters · filed 2018-02-27 | $34.85M derived: sum of 3 quarters · filed 2018-02-27 | $44.87M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $10.55M 10-Q · filed 2016-11-01 | $10.55M 10-Q · filed 2015-11-03 | $21.02M derived: sum of 2 quarters · filed 2016-11-01 | $31.04M 10-Q · filed 2016-11-01 | $31.04M 10-Q · filed 2015-11-03 | $42.20M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $10.47M 10-Q · filed 2016-08-01 | $10.47M 10-Q · filed 2015-08-04 | $20.49M 10-Q · filed 2016-08-01 | $20.49M 10-Q · filed 2015-08-04 | $31.66M derived: sum of 3 quarters · filed 2017-02-24 | $43.43M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $10.02M 10-Q · filed 2016-05-03 | $10.02M 10-Q · filed 2015-05-04 | $21.18M derived: sum of 2 quarters · filed 2017-02-24 | $32.95M derived: sum of 3 quarters · filed 2017-02-24 | $44.02M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $11.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $22.94M derived: sum of 2 quarters · filed 2017-02-24 | $34.01M derived: sum of 3 quarters · filed 2017-02-24 | $44.15M 10-K · filed 2017-02-24 | $44.15M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $11.77M 10-Q · filed 2015-11-03 | $22.84M derived: sum of 2 quarters · filed 2015-11-03 | $32.98M 10-Q · filed 2015-11-03 | $43.80M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $11.07M 10-Q · filed 2015-08-04 | $21.21M 10-Q · filed 2015-08-04 | $32.03M derived: sum of 3 quarters · filed 2016-03-10 | $42.02M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $10.14M 10-Q · filed 2015-05-04 | $20.96M derived: sum of 2 quarters · filed 2016-03-10 | $30.95M derived: sum of 3 quarters · filed 2016-03-10 | $42.38M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | $10.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $20.81M derived: sum of 2 quarters · filed 2016-03-10 | $32.24M derived: sum of 3 quarters · filed 2016-03-10 | $42.47M 10-K · filed 2016-03-10 | $42.47M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $9.99M 10-Q · filed 2014-11-06 | $21.42M derived: sum of 2 quarters · filed 2014-11-06 | $31.65M 10-Q · filed 2014-11-06 | $46.47M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $11.43M 10-Q · filed 2014-08-04 | $21.67M 10-Q · filed 2014-08-04 | $36.48M derived: sum of 3 quarters · filed 2015-03-13 | $48.52M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $10.24M 10-Q · filed 2014-05-05 | $25.05M derived: sum of 2 quarters · filed 2015-03-13 | $37.09M derived: sum of 3 quarters · filed 2015-03-13 | $50.58M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $14.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $26.85M derived: sum of 2 quarters · filed 2015-03-13 | $40.35M derived: sum of 3 quarters · filed 2015-03-13 | $51.64M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $12.04M 10-Q · filed 2013-11-05 | $25.53M derived: sum of 2 quarters · filed 2013-11-05 | $36.83M 10-Q · filed 2013-11-05 | $50.36M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $13.49M 10-Q · filed 2013-08-06 | $24.79M 10-Q · filed 2013-08-06 | $38.32M derived: sum of 3 quarters · filed 2014-03-13 | $51.96M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $11.30M 10-Q · filed 2013-05-06 | $24.83M derived: sum of 2 quarters · filed 2014-03-13 | $38.46M derived: sum of 3 quarters · filed 2014-03-13 | $50.93M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $13.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $27.17M derived: sum of 2 quarters · filed 2014-03-13 | $39.63M derived: sum of 3 quarters · filed 2014-03-13 | $50.81M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $13.64M 10-Q · filed 2012-11-08 | $26.10M derived: sum of 2 quarters · filed 2012-11-08 | $37.28M 10-Q · filed 2012-11-08 | $49.53M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $12.46M 10-Q · filed 2012-08-07 | $23.64M 10-Q · filed 2012-08-07 | $35.89M derived: sum of 3 quarters · filed 2013-03-14 | $47.68M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $11.18M 10-Q · filed 2012-05-07 | $23.42M derived: sum of 2 quarters · filed 2013-03-14 | $35.22M derived: sum of 3 quarters · filed 2013-03-14 | $47.91M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $12.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $24.03M derived: sum of 2 quarters · filed 2013-03-14 | $36.73M derived: sum of 3 quarters · filed 2013-03-14 | $48.02M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $11.79M 10-Q · filed 2011-11-04 | $24.49M derived: sum of 2 quarters · filed 2011-11-04 | $35.78M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $12.70M 10-Q/A · filed 2011-08-10 | $23.98M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $34.55M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |